Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma
Osteosarcoma (OS) is the most common human primary bone cancer, primarily affecting children and young adults. While the survival rate of patients diagnosed with localized OS is ∼65%, this decreases to ∼20% for patients with metastatic disease, and recurrent disease remains largely incurable. Therefore, identifying new therapeutic strategies is urgently needed for metastatic and refractory OS. This study analyzes the surfaceomes and global proteomes of 22 unique OS patient-derived xenografts (PDXs) using mass spectrometry to identify surface proteins for potential immunotherapeutic targeting. Both methods identify known OS-associated surface candidates including LRRC15, MMP14, MRC2, and CADM1, and several poorly characterized targets, including ROR2 and TMEM119. Both ROR2 and TMEM119 display robust expression in OS tissues but only limited or no expression in normal pediatric tissues, and loss of both targets reduces the migration of OS cells. These data provide a resource of surface proteins as potential immunotherapeutic targets in OS.
Authors
- John M. Maris (ORCID: https://orcid.org/0000-0002-8088-7929)
- E. Alejandro Sweet‐Cordero (ORCID: https://orcid.org/0000-0002-9787-9351)
- Gregg B. Morin (ORCID: https://orcid.org/0000-0001-8949-4374)
- Rawan Shraim (ORCID: https://orcid.org/0009-0005-5350-3386)
- Yogesh Budhathoki (ORCID: https://orcid.org/0009-0009-1278-6278)
- Michael M. Lizardo (ORCID: https://orcid.org/0000-0003-3981-0978)
- Alberto Delaidelli (ORCID: https://orcid.org/0000-0001-7416-6503)
- Gian Luca Negri (ORCID: https://orcid.org/0000-0001-7722-8888)
- Sharon J. Diskin (ORCID: https://orcid.org/0000-0002-7200-8939)
- Brian Mooney (ORCID: https://orcid.org/0009-0003-2834-9781)
- Mélanie Rouleau (ORCID: https://orcid.org/0000-0003-4154-3127)
- Poul H. Sorensen (ORCID: https://orcid.org/0000-0001-7447-2199)
- Wendong Zhang (ORCID: https://orcid.org/0000-0003-1762-9246)
- Amber K Hamilton
- Sruthi Magesh
- Richard Gorlick
- Harley Song
- Ryan Roberts
- Alison Marsh
- Yue Z. Huang
- Matthew V. Cannon
- Sandra E. Spencer
- Wei Li
- Xiaojie Chu
Institutions
- BC Cancer Agency (CA)
- Nationwide Children's Hospital (US)
- Children's Hospital of Philadelphia (US)
- The University of Texas MD Anderson Cancer Center (US)
- Harvard University (US)
- University of British Columbia (CA)
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Spinal Cord Injury BC (CA)
- Terry Fox Research Institute (CA)
- Mass General Brigham (US)
Publication Details
- Journal
- Cell Reports
- Published
- 2026-08-26
- DOI
- https://doi.org/10.1016/j.celrep.2026.117884
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- St. Baldrick's Foundation
- Break Through Cancer
- Osteosarcoma Institute
- Children’s Oncology Group
- Michael Smith Health Research BC
- National Cancer Institute